Revisional Surgery for Laparoscopic Minigastric Bypass
Overview
Affiliations
Background: Laparoscopic minigastric bypass (LMGB), a sleeved gastric tube with Billroth II anastomosis, has been proposed as an alternative to laparoscopic Roux-en-Y gastric bypass (LRYGB) for morbid obesity. However, the data regarding revision surgery after LMGB during long-term follow-up is not clear.
Methods: From January 2001 to December 2009, 1322 patients (996 women and 326 men, mean age 31.6 ± 9.1 years, mean body mass index 40.2 ± 7.4 kg/m(2)), who were enrolled in a surgically supervised weight loss program and had undergone LMGB were included. All the patients received regular yearly follow-up, and all the clinical data were prospectively collected and stored. The reasons and type of surgery for revision surgery were identified and analyzed.
Results: The excess weight loss and mean body mass index at 5 years after LMGB was 72.1% and 27.1 ± 4.6 kg/m(2). Of the 1322 patients, 23 (1.7%) had undergone revision surgery during a follow-up of 9 years. The estimated accumulated revision rate of 9 years was 2.69% for LMGB. The most common cause of revision was malnutrition in 9 (39.1%), followed by inadequate weight loss in 8 (34.7%), and intractable bile reflux and dissatisfaction each in 3 (13.0%). The type of revision surgery was LRYGB in 11 (47.8%), sleeve gastrectomy in 10 (43.5%), and conversion to a normal anatomic state in 2 (8.6%). All the revision procedures were performed using a laparoscopic approach, without major complications. Two patients underwent repeat second revision surgery to duodenal switch and biliopancreatic diversion each in 1 patient. All patients had satisfactory results after revision surgery. No patients had undergone revision surgery for internal hernia or ileus during the follow-up period.
Conclusion: LMGB resulted in significant and sustained weight loss with an acceptably low revision rate at long-term follow-up. Revision surgery after LMGB can be performed using a laparoscopic approach with a low risk.
Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity.
Amin U, Huang D, Dhir A, Shindler A, Franks A, Thomas C Gut Microbes. 2024; 16(1):2427312.
PMID: 39551972 PMC: 11581163. DOI: 10.1080/19490976.2024.2427312.
Hany M, Ibrahim M, Abouelnasr A, Torensma B Obes Surg. 2024; 34(10):3932-3934.
PMID: 39182002 PMC: 11464585. DOI: 10.1007/s11695-024-07456-2.
Boustani P, Mokhber S, Riazi S, Shahmiri S, Pazouki A Langenbecks Arch Surg. 2024; 409(1):259.
PMID: 39172234 DOI: 10.1007/s00423-024-03443-4.
Mostafapour E, Shahsavan M, Shahmiri S, Jawhar N, Ghanem O, Kermansaravi M BMC Surg. 2024; 24(1):156.
PMID: 38755612 PMC: 11097460. DOI: 10.1186/s12893-024-02438-8.
Quint E, Perry Z, Elkrinawi N, Kukeev I, Czeiger D, Vakhrushev A Obes Surg. 2024; 34(5):1756-1763.
PMID: 38557949 DOI: 10.1007/s11695-024-07194-5.